Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Candesartan and renal protection: more than blocking angiotensin type 1 receptor? — Daniela Macconi (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?
Shared by
Giuseppe Remuzzi
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?
Article
2008
en
Authors
DM
Daniela Macconi
Giuseppe Remuzzi
Related publications
Article
2006
Angiotensin-Receptor Blockers for Renal Protection in Type 2 Diabetes
Piero Ruggenenti
,
Manuel Macı́a
,
Giuseppe Remuzzi
Article
2005
Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade
Aneliya Parvanova
,
Carlos Chiurchiu
,
Piero Ruggenenti
,
Giuseppe Remuzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2009
Increased angiotensin-receptor blocking is not the first option
Piero Ruggenenti
,
Paolo Cravedi
,
Giuseppe Remuzzi
Article
2015
Early renin‐angiotensin system intervention is more beneficial than late intervention in delaying end‐stage renal disease in patients with type 2 diabetes
Bauke Schievink
,
Tobias F. Kröpelin
,
Skander Mulder
,
H.‐H. Parving
,
Giuseppe Remuzzi
,
Jamie P. Dwyer
,
Pepijn Vemer
,
Dick de Zeeuw
,
Hiddo J.L. Heerspink
Article
2005
Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients
Carlos Chiurchiu
,
Giuseppe Remuzzi
,
Piero Ruggenenti
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.